These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17474356)
1. Is there a role for hemopoietic stem-cell transplantation in CTCL? Dearden C Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):24-8. PubMed ID: 17474356 [TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
3. Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation. Herbert KE; Spencer A; Grigg A; Ryan G; McCormack C; Prince HM Bone Marrow Transplant; 2004 Sep; 34(6):521-5. PubMed ID: 15286686 [TBL] [Abstract][Full Text] [Related]
4. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas. Shustov A Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377 [TBL] [Abstract][Full Text] [Related]
10. The role of hematopoietic stem-cell transplantation in cutaneous T-cell lymphoma. Hoff NP; Bruch-Gerharz D G Ital Dermatol Venereol; 2010 Jun; 145(3):345-59. PubMed ID: 20461043 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Edelson RL Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563 [TBL] [Abstract][Full Text] [Related]
12. [Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma]. Stranzenbach R; Theurich S; Schlaak M Hautarzt; 2017 Sep; 68(9):716-720. PubMed ID: 28785925 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Paralkar VR; Nasta SD; Morrissey K; Smith J; Vassilev P; Martin ME; Goldstein SC; Loren A; Rook AH; Kim EJ; Porter DL Bone Marrow Transplant; 2012 Jul; 47(7):940-5. PubMed ID: 22020023 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas". Moritz RK; Ditschkowski M; Klemke CD; Terras S; Schlaak M; Knorr M; Theurich S; Hegenbart U; Kremens B; Beelen DW; Stücker M; Kreuter A; J Dtsch Dermatol Ges; 2014 Jan; 12(1):39-46. PubMed ID: 24134607 [TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
16. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389 [TBL] [Abstract][Full Text] [Related]
17. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680 [TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Dietrich S; Andrulis M; Hegenbart U; Schmitt T; Bellos F; Martens UM; Meissner J; Krämer A; Ho AD; Dreger P Biol Blood Marrow Transplant; 2011 Aug; 17(8):1250-4. PubMed ID: 21215813 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic transplantation in lymphoma: current status. Schmitz N; Dreger P; Glass B; Sureda A Haematologica; 2007 Nov; 92(11):1533-48. PubMed ID: 18024402 [TBL] [Abstract][Full Text] [Related]
20. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation. Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]